^
Association details:
Biomarker:No biomarker
Cancer:Colon Cancer
Drug:Fruzaqla (fruquintinib) (VEGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
11/16/2023
Excerpt:
Colon Cancer: SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Fruquintinib…